Maternal diabetes: the risk for specific birth defects - PubMed (original) (raw)

Maternal diabetes: the risk for specific birth defects

M A Ramos-Arroyo et al. Eur J Epidemiol. 1992 Jul.

Abstract

We studied the risk for specific birth defects among infants of mothers with gestational and chronic diabetes using data collected by the Spanish Collaborative Study of Congenital Malformations (ECEMC). For the years 1976 to 1985, we identified 10,087 infants with malformations and 9,994 control infants; 155 of the case infants and 89 of the controls were born to diabetic mothers. The crude odds ratio for any minor or major defect and insulin-treated diabetes was 5.5 (95% CI = 1.2, 24.8), and for major malformations it was 8.7 (95% CI = 1.8, 34.7). The risk for defects involving the central nervous system (CNS), skeletal system and cardiovascular system were significantly increased. Infants of non-insulin-treated diabetic mothers were 2.9 times more likely to have a major congenital birth defect (95% CI = 1.2, 7.2). The crude odds ratio for any major or minor defect and mothers with gestational diabetes requiring insulin was 1.9 (95% CI = 1.1, 3.4). Similar risk was observed for major defects (OR = 1.9, 95% CI = 1.0, 3.7). These results suggest that infants of insulin-treated diabetic mothers have an increased risk of developing malformations of the CNS, cardiovascular system and skeletal system. We also found an increased risk for specific defect categories among infants of mothers with gestational diabetes treated with insulin.

PubMed Disclaimer

Similar articles

• Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study.
  Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Becerra JE, et al. Pediatrics. 1990 Jan;85(1):1-9. Pediatrics. 1990. PMID: 2404255
• Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997-2011.
  Tinker SC, Gilboa SM, Moore CA, Waller DK, Simeone RM, Kim SY, Jamieson DJ, Botto LD, Reefhuis J; National Birth Defects Prevention Study. Tinker SC, et al. Am J Obstet Gynecol. 2020 Feb;222(2):176.e1-176.e11. doi: 10.1016/j.ajog.2019.08.028. Epub 2019 Aug 24. Am J Obstet Gynecol. 2020. PMID: 31454511 Free PMC article.
• [Maternal insulin-dependent diabetes and congenital malformations in the newborn].
  Kalaĭdzhieva M, Popivanova A, Doĭcheva E, Nikolov A, Dimitgrov A. Kalaĭdzhieva M, et al. Akush Ginekol (Sofiia). 2003;42(3):3-5. Akush Ginekol (Sofiia). 2003. PMID: 12858481 Bulgarian.
• Factors affecting risks of congenital malformations. II. Effect of maternal diabetes on congenital malformations.
  Chung CS, Myrianthopoulos NC. Chung CS, et al. Birth Defects Orig Artic Ser. 1975;11(10):23-38. Birth Defects Orig Artic Ser. 1975. PMID: 769859 Review.
• Current status of pregnancy in diabetic women. A comparison of pregnancy in IDDM and NIDDM mothers.
  Omori Y, Minei S, Testuo T, Nemoto K, Shimizu M, Sanaka M. Omori Y, et al. Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S273-8. doi: 10.1016/0168-8227(94)90261-5. Diabetes Res Clin Pract. 1994. PMID: 7859618 Review.

Cited by

• Curcumin ameliorates high glucose-induced neural tube defects by suppressing cellular stress and apoptosis.
  Wu Y, Wang F, Reece EA, Yang P. Wu Y, et al. Am J Obstet Gynecol. 2015 Jun;212(6):802.e1-8. doi: 10.1016/j.ajog.2015.01.017. Epub 2015 Jan 13. Am J Obstet Gynecol. 2015. PMID: 25595578 Free PMC article.
• Vasoactive exposures during pregnancy and risk of microtia.
  Van Bennekom CM, Mitchell AA, Moore CA, Werler MM; National Birth Defects Prevention Study. Van Bennekom CM, et al. Birth Defects Res A Clin Mol Teratol. 2013 Jan;97(1):53-9. doi: 10.1002/bdra.23101. Epub 2012 Nov 24. Birth Defects Res A Clin Mol Teratol. 2013. PMID: 23180593 Free PMC article.
• Restoring BMP4 expression in vascular endothelial progenitors ameliorates maternal diabetes-induced apoptosis and neural tube defects.
  Cao S, Reece EA, Shen WB, Yang P. Cao S, et al. Cell Death Dis. 2020 Oct 15;11(10):859. doi: 10.1038/s41419-020-03078-5. Cell Death Dis. 2020. PMID: 33060561 Free PMC article.
• SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy.
  Weng H, Li X, Reece EA, Yang P. Weng H, et al. Am J Obstet Gynecol. 2012 May;206(5):448.e1-7. doi: 10.1016/j.ajog.2012.02.011. Epub 2012 Feb 22. Am J Obstet Gynecol. 2012. PMID: 22425406 Free PMC article.
• Maternal hyperglycemia inhibits pulmonary vasculogenesis during mouse fetal lung development by promoting GβL Ubiquitination-dependent mammalian target of Rapamycin assembly.
  Luo Q, Chai X, Xin X, Ouyang W, Deng F. Luo Q, et al. Diabetol Metab Syndr. 2023 Mar 17;15(1):49. doi: 10.1186/s13098-022-00974-y. Diabetol Metab Syndr. 2023. PMID: 36927703 Free PMC article.

References

1. 1. Am J Obstet Gynecol. 1982 Apr 15;142(8):1030-2 - PubMed
2. 1. Am J Obstet Gynecol. 1984 Apr 15;148(8):1111-8 - PubMed
3. 1. Lancet. 1964 May 23;1(7343):1124-6 - PubMed
4. 1. Rev Clin Esp. 1980 Nov 30;159(4):243-9 - PubMed
5. 1. Arch Dis Child. 1976 Dec;51(12):935-8 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Medical

  • MedlinePlus Health Information